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Abstract
Sugar is the main source of energy for all cells in the human body. On the other 
hand, cells can also obtain energy from fats and proteins depending on conditions, 
although this metabolic process is more difficult and less common in cells. Sugar 
intake has increased in recent decades and is included in most of our dietary prod-
ucts. However, many studies indicate that sugar intake increases the prevalence of 
suffering from various harmful health conditions such as obesity. As a consequence, 
obesity is related to several chronic diseases such as hypertension, insulin resistance, 
and diabetes mellitus in humans. This is due to an excessive intake of sugars and sed-
entary lifestyles, causing a deterioration in the organs of our body, and consequently, 
reducing life expectancy. In this chapter, sugars that both shorten and lengthen life 
expectancy are presented. The latter are recent options that have emerged in order to 
continue sweetening our food in a healthier way, and would be new geroprotectors.
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1. Introduction
Sugar is the main source of energy for the cells of the human body and is a 
nutrient that is abundantly found in nature and is widely used in the food pro-
cessing industry. In the 1970s and 1980s, a strong association was found between 
cardiovascular disease, the number 1 cause of death in the world, and fat intake. 
For this reason, the food industry began to create low-fat but high-sugar consumer 
products. Today there is evidence that the high consumption of sugars in the recent 
decades has triggered a lot of chronic diseases that were not previously known, as 
diabetes mellitus. The appearance of chronic diseases such as diabetes mellitus has 
increased exponentially. Diabetes mellitus, e.g., is considered today a pandemic, 
due to it is one of the most prevalent not transmissible diseases in the world. The 
role sugar intake that is linked to aging is now relevant to the global chronic disease 
epidemic [1]. The global nonalcoholic fatty liver disease epidemic also has now 
become of major concern to diabetes [2].
Many scientific studies show that the increase in chronic diseases is due to exces-
sive consumption of sugars and low-quality carbohydrates. This chapter presents in 
Section 2 the relationship between human life expectancy and sugar consumption, 
including a brief explanation of glucose metabolism in the human body. Later, 
Section 3 presents sugars as glucose, fructose, and galactose known as likely to 
shorten life with excessive intake. On the other hand, Section 4 presents sugar with 
potential to extend life expectancy like 2-deoxy-glucose, allulose, and glucosamine. 
Finally, the conclusions are presented.
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2. Interaction of lifespan and sugar
2.1 Sugar consumption in human
Humans are always aging. The progress of aging and the life span are affected by 
environmental factors inside and outside the living body. One of the most promis-
ing environmental factors is oxidative stress. The free radical theory of aging is 
based on the idea that active oxygen, which is a causative agent of oxidative stress, 
oxidatively damages biomolecules and causes their accumulation to cause a decline 
in cell function, which causes aging [3]. Active oxygen is considered as a cause of 
various diseases as well as aging. Therefore, “antioxidant therapy” has been devised, 
which aims to treat diseases by controlling active oxygen as a toxic factor.
The generation of active oxygen is largely related to mitochondria. The main 
physiological role of mitochondria is to produce energy, or ATP. The ATP synthetic 
pathway includes anaerobic glycolysis that does not require oxygen and aerobic 
oxidative phosphorylation that requires oxygen [4]. The primary function of 
mitochondria is this oxidative phosphorylation. That is, by utilizing oxygen, 
more ATP is produced more efficiently than the glycolytic system. This oxidative 
phosphorylation is carried out by the electron transfer system existing in the inner 
mitochondrial membrane. About 100 kinds of proteins are involved in the electron 
transfer system, and various enzymes form a complex (Complex I to IV). In mito-
chondria, surprisingly, in addition to oxidative phosphorylation, metabolism such 
as ion channels, intracellular calcium homeostasis, fatty acid β-oxidation, neutral 
fat cycle, urea cycle, amino, fat, heme, purine, steroid and steroid hormone syn-
thesis. It has various functions related to. Normally, 2 to 3% of electrons leak from 
the electron transport system, and the leaked electrons react with the most reactive 
oxygen molecule in the vicinity to produce superoxide.
Active oxygen is generated not only by external factors but also by internal 
factors. In mitochondria, active oxygen is produced as a by-product during the 
process of energy production. Some phagocytic cells produce active oxygen for the 
treatment of foreign substances such as bacteria. In some aspects, active oxygen is 
not necessarily an unfavorable existence for living things. Subsequent studies have 
revealed that active oxygen has a role as a physiologically active substance and a 
redox signal molecule [5, 6].
2.2 ROS generation and mitochondrial respiration
Complex I and Complex III are well known as the main generation sites of 
superoxide [7, 8]. Complex II also contributes to active oxygen produced from 
mitochondria [9]. Other mitochondrial enzymes that are not directly involved in 
the electron transport system also play a part in the production of mitochondrial 
active oxygen, and dihydroorotic acid oxidase is a by-product during the conversion 
of dihydroorotic acid to orotic acid and also the TCA (tricarboxylic acid) cycle. 
It has been reported that α-ketoglutarate dehydrogenase, which is an enzyme of 
Escherichia coli, also produces NADH/NAD+-dependent active oxygen [10, 11].
The mitochondrial oxidative metabolism of glucose is the most commonly 
known mechanism through which the ingestion of carbohydrates generates oxida-
tive stress. Mitochondrial oxidative metabolism of glucose leads to the generation 
of reactive oxygen species (ROS). When glucose intake is high, glucose levels in the 
bloodstream rise, increasing many metabolic processes inside the cells regarding 
glucose metabolism, consequently increasing the ROS, and including the auto-oxi-
dation, through the mitochondria. The mitochondrial respiration chain generates 
free radicals as a result of electron transport and depletion of the oxygen molecule. 
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Higher glucose consumption in the cell from the mitochondria causes a higher num-
ber of ROS [12]. Several studies [13] indicate that ROS, extremely reactive chemical 
molecules, are the major cause of the aging process in humans.
2.3 Hormesis
Hormesis is a biphasic response to exposure to increasing amounts of a sub-
stance [14]. Within the hormesis, there is generally a relatively favorable biological 
response to low exposures to toxic substances and other stressors. The concept of 
hormesis has been explored extensively with respect to its applicability is aging 
[15]. Because the survival capacity of any biological system is dependent on its 
defensive ability, exposing organisms to stress is expected to result in the adaptive 
response with various benefits. This idea has now gathered a large body of sup-
portive evidence showing that repetitive mild stress exposure has anti-aging effects 
[16, 17]. Hormetic interventions have also been proposed at the clinical level [18], 
with a variety of stimuli, challenges and stressful actions, that aim to increase the 
dynamical complexity of the biological systems in humans [19].
ROS, which mentioned above, may perform an important lifespan-depending 
role as redox signaling molecules which transduce signals from the mitochondrial 
compartment to other compartments of the cell [20]. Increased temporarily forma-
tion of ROS within the mitochondria may cause an hormesis effect and reaction 
which induces increased stress resistance and a long-term reduction of oxidative 
stress. This type of reverse effect of the response to ROS stress has been named 
mitochondrial hormesis and is hypothesized to be responsible for the respective 
lifespan-extending capabilities of glucose restriction [20].
2.4 Sugar metabolism
Life is active. Energy is essential for activities. The most important source of 
energy for the cells of the human body is glucose. They create energy from glucose 
to stay alive and to carry out many metabolic processes in different organs and tis-
sues. Humans have easy access to glucose. Glucose enters the human body through 
the mouth, where it begins to be processed by the amylases contained in saliva [21]. 
After that, the glucose travels up the esophagus to the stomach. Glucose and carbo-
hydrates in general that reach the stomach do not undergo chemical or mechanical 
changes, since the enzymes that degrade them are not active at the acid pH that is 
in the stomach. The glucose then reaches the intestine, where it is absorbed into 
the bloodstream through the intestinal wall [21]. Then, glucose is metabolized in 
the liver thanks to the action of insulin. Excess glucose is stored as glycogen, while 
a quantity of glucose continues into the systemic circulation through the hepatic 
veins. Thus, glucose reaches all tissues to be used in cellular mitochondria as energy.
Glucose is absorbed quickly, whereas fructose is converted to glucose (10%) and 
the remaining 90% is absorbed as fructose. Sixty percent of the absorbed glucose 
is taken up by other tissues, such as the liver, 25% by the brain, 10% by muscle, and 
5% by adipose tissue [22]. Meanwhile, almost all of the absorbed fructose is taken 
up by the liver. The glucose and fructose taken up by the liver is consumed in the 
glycolytic system, through the TCA cycle, and in ATP production, with the excess 
converted to glycogen and triglycerides. However, there is a major metabolic differ-
ence between glucose and fructose in the liver. Glucose is regulated by the insulin-
dependent metabolic rate-limiting enzymes glucokinase, phospho-fructokinase, 
and glycogen synthase, but in the case of fructose, this regulatory mechanism does 
not work well. Fructose is mostly phosphorylated by fructokinase. However, there 
is no mechanism to control the phosphorylation of fructose and its subsequent 
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metabolism. Therefore, the influx of excess fructose into the liver leads to increased 
synthesis of triglycerides and release of triglycerides into the blood, resulting in 
hypertriglyceridemia because of the limited glycogen stores in the liver [23]. This 
process is especially active in diabetes mellitus with insufficient insulin action, 
because glycogen synthesis and ATP production are not as smooth as they could be.
3. Sugars with the potential to shorten human life
Glucose, fructose, and galactose are sugars that are likely to be short-lived with 
excessive intake. Specific characteristics of each one of them are presented in this 
section.
3.1 Glucose
Glucose is a simple sugar with the molecular formula C6H12O6, as shown in 
Figure 1. Glucose is the most abundant monosaccharide, a subcategory of carbo-
hydrates. Glucose is mainly made by plants and most algae during photosynthesis 
from water and carbon dioxide, using energy from sunlight, where it is used to 
make cellulose in cell walls, which is the most abundant carbohydrate [24]. In 
energy metabolism, glucose is the most important source of energy in all organ-
isms. Glucose for metabolism is stored as a polymer, in plants mainly as starch 
and amylopectin, and in animals and humans as glycogen. Glucose circulates in 
the blood of animals as blood sugar. Glucose in the blood is the source of energy 
for cells throughout the body and is supplied through food intake and transported 
through the bloodstream.
Excessive glucose intake is directly linked to diabetes. Diabetes mellitus is one 
of the most prevalent chronic non-communicable diseases today. Type 2 diabetes 
mellitus (DM) is a progressive disease by uncontrolled plasma glucose levels. In 
the epidemiological study drawn from the general population, random glucose 
consumption showed a significant association with all-cause mortality, independent 
of main potential confounders [25]. Thus, random glucose measures are highly 
relevant to health risk assessment among people without known diabetes when fast-
ing glucose or HbA1c is difficult to obtain.
DM results from a combination of factors affecting both insulin sensitivity and 
β-cell function. Chronic hyperglycemia imposes glucose toxicity on many cell types and 
is correlated with the myriad of DM-related complications [26]. Cells most vulnerable 
to the effects of prolonged elevated plasma glucose levels include pancreatic cells and 
vascular endothelial cells. The ensuing pancreatic dysfunction promotes decreased 
Figure 1. 
Linear chemical structure (left) and Haworth projection structure (right) of a glucose molecule.
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insulin secretion, further perpetuating the associated hyperglycemia. On the vascular 
endothelium, chronic hyperglycemia is correlated with some types of DM-related 
microvascular complications, including retinopathy and nephropathy [26].
3.2 Fructose
Fructose is contained in many fruits, vegetables, and honey. It is a monosac-
charide with the same molecular formula as glucose (C6H12O6), but with a different 
structure (see Figure 2), that is, it is an isomer of it. An increase intake of sugars, 
including fructose, in beverages is related to high prevalence of having obesity, type 
2 DM, insulin resistance, hyperinsulinemia, and hypertension in humans. These 
chronic diseases without a good treatment or if they are not well controlled, cause a 
decrease in life expectancy. Nowadays, there is little scientific evidence for the fruc-
tose and its relationship with life expectancy in humans. It is known that fructose 
metabolism mainly occurs in the enterocytes (cells of the small intestine), hepa-
tocytes (cells in the liver), and nephrons (cells in the kidneys) [27]. Nevertheless, 
few studies indicate that fructose could extend lifespan in some organisms as the 
nematode, fly and mice. This is due to life of many of those organisms, including 
yeast, is regulated by the insulin/IGF-1(Insulin-like Growth Factor-1)-signaling 
pathway [28].
On the other hand, high fructose corn syrup (HFCS) is commercially produced 
by isomerizing glucose to fructose. The taste quality of it is like sucrose and the 
price is affordable. This monosaccharide is a component of sucrose and is highly 
sweet (140% the sweetness of sucrose), leading to its frequent use in the food 
industry, particularly for beverage production. Thus, fructose consumption is 
common in the beverage industry, in which more sweetness is often needed [29]. In 
the field, fructose is used as a mixture of fructose and glucose, e.g., high fructose 
corn syrup, which is easy and inexpensive to manufacture from glucose. Thus, 
HFCS has been used for various foods such as beverages, confectionery, desserts 
and bakery. However, consumption of HFCS has been reported to be one of risk 
factors developing diabetes and obesity [30]. Sirtuin 1 is an anti-aging gene that 
becomes downregulated with relevance to the global chronic disease epidemic. 
Glucose and Fructose induce changes in Sirtuin 1 protein levels with relevance 
to induction of the metabolic syndrome and multiple organ disease syndrome 
[31]. Consumption of glucose and fructose should be carefully monitored with 
relevance to plasma Sirtuin 1 levels that now are connected to obesity, diabetes, 
NAFLD and neurodegenerative diseases [32]. Fructose induces gluconeogenesis 
and lipogenesis [33]. Excessive intake of fructose has been reported to result in 
short life [34].
Figure 2. 
Linear chemical structures of a fructose molecule (left) and a glucose molecule (right).
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3.3 Galactose
Galactose is a C-4 epimer of glucose, as can be seen in Figure 3. Galactose, 
along with fructose and glucose, is an essential simple sugar included in the human 
diet. Galactose is a component of lactose, the disaccharide of which is contained in 
approximately 10% of milk. Lactose is a disaccharide that makes up around 3–7% 
of milk [35] and is derived from the condensation of galactose and glucose, which 
forms a β-glycosidic bond. Therefore, galactose can be consumed individually or 
in combination with other sugars in the form of more complex carbohydrates [36] 
to be digested and absorbed mainly in the small intestine into the bloodstream. In 
addition to being absorbed through the small intestine, some reports indicate that 
the human body can produce galactose endogenously [37] under some metabolic 
disorders associated with genetic mutations in enzymes of the Leloir pathway [38].
Many volumes of the disaccharides are produced annually as a by-product of 
the dairy industry [39]. Milk is consumed by people worldwide. However, lactose 
in milk may cause health problems in individuals with lactose intolerance [40, 41]. 
Thus, methods for lactose degradation in milk have been extensively studied 
[42, 43] and the lactose-free milk is produced and commercialized. In this case, 
studies have been conducted to assess blood glucose levels when lactose-free milk is 
consumed and a tendency to hyperglycemia was found 2 hours after consumption 
even in healthy people. The condition of hyperglycemia can be caused because lac-
tose is ingested in its simplest forms, galactose, and glucose, and therefore it can be 
absorbed directly in the small intestine into the bloodstream, without going through 
digestion processes in the gastrointestinal tract. On the other hand, galactose can be 
produced industrially by lactase (β-galactosidase) derived from food microorgan-
isms [44]. However, due to its low sweetness and limited research regarding its 
safety and functions [45], utilization of pure galactose in the food industry is not yet 
widespread [46]. Many animal studies have showed galactose induced accelerated 
aging in rodents [47, 48].
4. Sugars with the potential to prolong human life
2-Deoxy-glucose (2DG), allulose (AL), and glucosamine (GN) are sugars that 
are likely to be prolong life with intake. These monosaccharides would be new 
geroprotectors. This section describes a brief detail of all of them.
4.1 2-Deoxy-glucose
2DG is a glucose analog in which the 2-hydroxyl group is replaced by a hydrogen 
atom, as shown in Figure 4. 2DG is not at all metabolized via glycolysis and was 
Figure 3. 
Linear chemical structures of a galactose molecule (left) and a glucose molecule (right).
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the first proposed calorie restriction mimetic [49]. It is considered to delay aging-
related diseases and prolong the lifespan by suppressing glycolytic activity [50]. 
Schulz et al. [51] suggested a detailed mechanism for the 2DG longevity effect in C. 
elegans based on a hypothesis named as “mitochondrial hormesis”. The hypothesis 
means that induction of mitochondrial metabolism may trigger a positive response 
to increased formation of ROS, leading to a hermetic increase in defense for stresses, 
resulting in decreased total stress levels. Inhibition of glycolysis by 2DG induces the 
utilization of stored lipid and mitochondrial respiration via AMPK (AMP-activated 
protein kinase). In a study comparing the effects of 2DG and calorie restriction in 
rodents, 2DG administration showed the same effects on locomotory activity, heart 
rate, and blood pressure as calorie restriction [52].
The same group of rodents demonstrated the protective effect of 2DG against 
glutamate excitotoxicity and upregulation of stress response proteins, in hippo-
campal cells [53]. Moreover, the same group demonstrated an improved behavioral 
outcome of 2DG treatment and reduced degeneration of dopaminergic neurons in a 
Parkinson’s disease model [54], as well as decreases in proliferating cell nuclear anti-
gen and bromodeoxyuridine-positive tumor cells [55]. On the other hand, a study 
in nematodes [56] found that the magnitude of gene expression values changes 
significantly when they are feeding with 2DG, the change is proportional to the age, 
but the most important thing is that their lifespan could be considerably extended.
Although 2DG shows the same effects as calorie restriction, few studies have 
examined its ability to extend lifespan. Rather, long-term 2DG ingestion induced 
heart vacuolation in rats and increased mortality [57]. However, 2DG is considered 
a potential caloric restriction mimetic due to it has effects on the metabolism that 
might regulate increases of the stress responses which protect against several aging 
processes, by improving longevity without a reduction or complete suppression 
of food intake. In this sense, Ingram et al. [58] shown that the use of 2DG reduces 
body temperatures, Dark et al. [59] report an increment of lethargy, Wan et al. [60] 
support a reduction of heart rate, and other studies indicate a declination of insulin 
and glucose blood levels [61, 62].
4.2 Allulose
Allulose (AL; psicose), a C-3 epimer of fructose (see Figure 5), is a rare hexose 
sugar present in a limited quantity in nature. In fact, this compound is isolated from 
natural products marketed as a functional sweetener with zero calories [62], easy to 
produce from d-fructose, in order to use it as a healthier sweetener in industrialized 
products.
In the previous decade, numerous studies showed that AL exhibits various 
activities, such as antihyperglycemic and antiobesity effects [63, 64], increment 
in the insulin sensitivity, attenuate cognitive impairment, delay diseases of aging, 
Figure 4. 
Linear chemical structures of a 2-deoxy-glucose molecule (left) and a glucose molecule (right).
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slow down cardiac aging, and prolong median life span [65, 66]. Toyoda et al. [67] 
reported that long-term administration of AL maintained glucose tolerance and 
insulin sensitivity in rats via hepatic glucokinase activation. Thus, AL is expected 
to be a potent antidiabetic sweetener. AL enters cells through glucose transporters 
and inhibits glycolysis, inducing the metabolism of stored fat and mitochondrial 
respiration via AMPK. Increased respiration causes temporary upregulation of ROS 
production, leading to increased antioxidant activity, oxidative stress resistance, 
and survival rates [68]. Although sirtuin is reported to be antiaging gene and 
a diagnostic marker to chronic disease [31], AL-mediated lifespan extension is 
independent of sirtuin gene.
In a clinical trial, AL was shown to be a geroprotector based on changes in 
biomarker levels such as glucose and body fat. A clinical trial using a standard meal 
confirmed that AL suppresses postprandial blood glucose levels [69]. Even a single 
dose of AL was reported to enhance postprandial fat oxidation in healthy humans 
[70]. Upon continuous intake of AL, the percentage of body fat and body fat mass 
significantly decreased, with no significant reduction in nutrient intake [71].
4.3 Glucosamine
GlcN is, a one of glucose derivatives, 2-amino-2-deoxy-glucose, as can be seen 
in Figure 6. GlcN is part of the structure of two polysaccharides, chitosan and 
chitin. GlcN is the fluid that surrounds the joints, but also is a constitutional unit 
of chitosan, which are contained in arthropods and cephalopods. In food industry, 
GlcN is manufactured by the hydrolysis of crustacean exoskeletons, which are 
mainly composed of chitin. GlcN is a dietary supplement that effectively prevents 
osteoarthritis in humans [72].
Weimer et al. reported the longevity effects of GlcN in nematodes and geneti-
cally modified mice [73]. The authors suggested that these effects were caused by 
impaired glucose metabolism. In contrast, the longevity effect of GlcN is reported 
to be required an autophagy for GlcN-induced lifespan extension [68], like that 
induced by other life-promoting sugars such as 2DG. Similar to 2DG, GlcN enters 
into cells through sugar transporters and inhibits glucose metabolism, inducing the 
oxidation of stored fat and intracellular respiration via an energy sensor (AMPK). 
Increased respiration can cause temporary production of ROS, leading to increases 
in antioxidative enzyme activity, stress resistance, and lifespan [74]. This effect is 
hormesis, mentioned above. Oral administration of GlcN has also been reported 
to affect carbohydrate metabolism and reduce fat in rodents [75] and contribute to 
enhanced oxidative stress resistance, followed by AMPK activation [74].
In a clinical trial, administration of GlcN improved vascular endothelial 
function by modulating the intracellular redox state [76]. According to an 
Figure 5. 
Linear chemical structures of an allulose molecule (left) and a fructose molecule (right).
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epidemiological study on consumers of various dietary supplements, the use of 
GlcN was associated with a decrease in total mortality [77]. Of further note is the 
latest large-scale cohort study reported in 2020. This study analyzed approximately 
500,000 people and found that GlcN intake reduced the risk of cancer, heart 
disease, respiratory disease, digestive disease, and mortality [78].
5. Geroprotectors
“Geroprotector”, whose technical term Ilya Mechnikov first used in 1908 [79], 
means “protecting against aging”. The most important criterion of geroprotector is 
the ability to extend the lifespan of model organisms such as nematode fly and mice 
[80]. In 2001, Vladimir Anisimov suggested several types of geroprotectors using 
the most recognized theories of aging at that time as the typing criteria, which 
included antioxidants, neurotropic substances, hormones, antidiabetic drugs, 
immunomodulators, caloric restriction mimetics, and other substances and factors 
[81]. In the present, the various types would add longevity gene activators, includ-
ing nicotinamide mononucleotide [82] and sirtuin activating compounds [83], as a 
new group to these conventional geroprotectors. Other new geroprotectors contain 
melatonin [84], and carnosine [85]. Among geroprotectors, the monosaccharides 
with the potential to prolong lifespan, mentioned in this chapter, is included in 
category of caloric restriction mimetics [49, 50]. This type of caloric restriction 
mimetics, whose action is considered glycolytic inhibition, mimics the anti-aging 
effects of long-term calorie restriction without requiring a change in eating 
 habits [68].
6. Conclusion
Sugar consumption has increased since the 1990s when scientific studies found 
a strong association between fat consumption and cardiovascular problems. Since 
then, fats were almost sensed and sugars and carbohydrates were given prior-
ity. Sugar consumption has increased so much that it has triggered an enormous 
number of chronic diseases such as obesity and diabetes mellitus that, even today, 
have been declared a pandemic and a global emergency. Diseases caused by high 
sugar consumption generate a decline in the organs of the human body, which is 
closely linked to premature aging or a significant reduction in the quality of life of 
the people who suffer from them. In this regard, many studies have evidence that 
sugar intake to have effects in the human body associated with diseases as obesity 
and diabetes mellitus, however, little was until recently known about the effects 
Figure 6. 
Linear chemical structures of a glucosamine molecule (left) and a glucose molecule (right).
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of sugars on lifespan. As mentioned in this chapter, sugars that both shorten and 
lengthen life expectancy was presented. The good options with antiaging effect of 
the sugars have emerged in order to continue sweetening our food in a healthier 
way. It would be new geroprotectors in the near future.
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